INS and delirium: Based on these findings, this study was designed to evaluate the efficacy of melatonin supplementation on FBS and insulin resistance parameters as primary outcomes and also; GCS, delirium, ventilator dependency, ICU stay, and mortality rate as secondary outcomes in critically ill traumatic and medical patients with SIH.